Module

Update on HIV/HBV Coinfection

Source: HIV/AIDS Annual Update 2007

Update on HIV/HBV Coinfection


Faculty:

  • Marion G. Peters, MD, FRACP

CME CREDIT INFORMATION

Release Date: 08/14/07

Expiration Date: 08/13/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the effects of HIV on the clinical course of hepatitis B virus (HBV) infection
  • Discuss the effects of HBV on the clinical course of HIV infection
  • Explain approaches to the treatment of HIV/HBV coinfection

Topics covered include:

  • Introduction
  • Impact of HIV on HBV Disease Outcomes
  • Impact of HBV on HIV Disease Progression
  • Goals of HBV Therapy in the HIV/HBV-Coinfected Patient
  • Selection of Antiviral Therapies in HIV/HBV-Coinfected Patients
  • Therapies for HBV Infection
  • Use of Combination Therapy for HBV Infection
  • Summary: Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.